2013 CONSULTATION RESPONSES

The Royal Pharmaceutical Society responded to the following consultations in 2013.

January 2013

Consultation on standards for prescribing | The Health & Care Professions Council (HCPC)

Information Governance Toolkit | NHS Commissioning Board

Strengthening the NHS Constitution | Department of Health (DH)

February 2013

Request to reclassify Pirinase Hayfever Relief for Adults 0.05% Nasal Spray (fluticasone propionate) from Pharmacy (P) to General Sales List (GSL) | Medicines and Healthcare products Regulatory Agency (MHRA)

Veterinary Medicines Regulations 2013 Formal Public Consultation | Veterinary Medicines Directorate (VMD)

Consultation to collect views about whether a Public Health Bill is needed in Wales | Welsh Government

Review of the balance of competencies: Call for evidence | DH

A narrative for person-centred coordinated ('integrated') care | NHS Commisioning Board

March 2013

Together for health - A diabetes delivery plan | Welsh Government

April 2013

ARM 84: Reclassify Anusol Advance Suppositories from Pharmacy (P) to General Sales List (GSL) | MHRA

ARM 85: Reclassify Anusol Advance Ointment from Pharmacy (P) to General Sales List (GSL) | MHRA

Smoking cessation: supporting people to stop smoking | National Institute for Health and Clinical Excellence (NICE)

Direct payments for healthcare | DH

May 2013

Health Care and Associated Professions (indemnity Arrangements) Order 2013 | DH

June 2013

Informal consultation to amend the Human Medicines Regulations 2012 | MHRA

Whistle blowing Commission | Public Concern at Work

MLX 381- Proposals for amendments to medicines legislation to allow sale of medicines on trains and planes | MHRA

August 2013

Migrant access and their financial contribution to NHS provision in England | DH

Changes to the way CQC regulates, inspects and monitors care | CQC

High quality care for all, now and for future generations: transforming urgent and emergency care services in England | NHS England

September 2013

Amendments on the ABPI Code of Practice for the Pharmaceutical Industry and the PMCPA Constitution and Procedure | Prescription Medicines Code of Practice Authority (PMCPA)

Call for Evidence: Inquiry into the work of Healthcare Inspectorate Wales | National Assembly for Wales

Call for Evidence: Stroke Risk Reduction - Follow-up Inquiry | National Assembly for Wales

Regulations to specify the drugs and corresponding limits for the new offence of driving with a specified controlled drug in the body above the specified limit  |  UKCPA Response | Department of Transport

Right care,right place,right time:How we can improve health and care for vulnerable older people | DH

Government consultation on the Mandate Refresh for 2014-2015 | DH

October 2013

Scheduling of tramadol and a review of the exemptions for temazepam prescriptions under the Misuse of Drugs Regulations 2001 | Home Office

Medicines Optimisation - scope consultation | NICE

Osteoarthritis (update): guideline consultation | NICE

Availability of Diclofenac as a Pharmacy medicine | MHRA

A Framework for Delivering Integrated Health and Social Care - For Older People with Complex Needs | Welsh Government

Proposals for amendments to the Medicines, medical devices, treatments and health section of the BCAP Code | Broadcast Committee of Advertising Practice (BCAP)

November 2013

Needle and syringe programmes (update): NICE guideline consultation |  NICE

A Framework for Health and Social Care Integration for Older People with Complex Needs |  Welsh Government

Weight management before, during and after pregnancy public health guidance |  NICE

Identifying and supporting people most at risk of dying prematurely | NICE

Low Back Pain (update) | NICE

Enabling a sustainable supply of pharmacy graduates | Higher Education Council for England (HEFCE)

Enabling a sustainable supply of pharmacy graduates: Annex B | Higher Education Council for England (HEFCE)

Older people with long-term conditions draft response | NICE

December 2013

Public Health Draft Guidance - Managing overweight and obesity in adults - lifestyle weight management services | NICE

Draft guideline scope Obesity: the prevention, identification, assessment and management of overweight and obesity in children, young people and adults | NICE

Draft scope guideline for motor neurone disease | NICE

Managing Medicines in Care Homes: Good Practice Guidance Stakeholder Consultation | NICE

Draft Quality Standards Conduct disorders in children and young people | NICE

Quality Standards Consultation - Infection Control | NICE

Quality Standards Consultation on Sickle Cell Crisis | NICE

Consultation on potential future public health quality standard topics | NICE